Gene · 3159
Papers3,810
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 3,810
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Heat-preconditioned MSC-derived exosomal miR‑486‑5p reverses doxorubicin resistance in breast cancer. | Nanomedicine (Lond) | 2026 | 42821374 | PubTator, text mining | PubMed |
| ERRATUM to: Intracellular FGF1 promotes invasion and migration in thyroid carcinoma via HMGA1 independent of FGF receptors. | Endocr Connect | 2026 | 42743414 | PubTator, text mining | PubMed |
| Pan-cancer characterization of HMGA1 reveals its oncogenic role in tumor microenvironment and stemness: functional validation in pancreatic cancer migration and invasion. | Transl Cancer Res | 2026 | 42724846 | PubTator, text mining | PubMed |
| Targeting MYCN Degradation by HLB-0532259 Induces Senescence in Retinoblastoma. | Invest Ophthalmol Vis Sci | 2026 | 42615797 | PubTator, text mining | PubMed |
| Identifying Epithelial-Cell Progression Signatures (ECPSs) from Multi-Resolution Multi-Omics Data for Translational Clinical Applications in Lung Adenocarcinoma. | Int J Mol Sci | 2026 | 42589474 | PubTator, text mining | PubMed |
| HMGA1 is associated with unfavorable outcome and accelerates the aggressiveness of cholangiocarcinoma. | SAGE Open Med | 2026 | 42558860 | PubTator, text mining | PubMed |
| A five-gene TAM and MYCN signature predicts prognosis and identifies MTHFD2 as a therapeutic target in neuroblastoma. | Discov Oncol | 2026 | 42550464 | PubTator, text mining | PubMed |
| Tumor-associated macrophages and lineage plasticity in prostate cancer: from established myeloid programs to emerging spatial hypotheses. | Front Immunol | 2026 | 42516385 | PubTator, text mining | PubMed |
| Differentially Methylated Regions in Human Rhombic Lip Compartments Are Enriched in Putative Active Enhancers, Human Accelerated Regions, and Medulloblastoma Copy Number Aberrations. | Cerebellum | 2026 | 42479105 | PubTator, text mining | PubMed |
| Biomarkers of the tumor microenvironment for prognostication of recurrence in glioma and targeting stemness using an adjuvant. | Discov Oncol | 2026 | 42471533 | PubTator, text mining | PubMed |
| MAP2K6 reprograms NAD+ metabolism via the HMGA1-NAMPT axis to sensitize ovarian cancer cells to PARP inhibition. | Cell Death Dis | 2026 | 42469197 | PubTator, text mining | PubMed |
| RETRACTION: Loss of Hmga1 gene function affects embryonic stem cell lymphohematopoietic differentiation. | FASEB J | 2026 | 42461233 | PubTator, text mining | PubMed |
| Dementia, mood disorders, and aging: Bridging new avenues of care through shared biological pathways. | Aging Adv | 2026 | 42370305 | PubTator, text mining | PubMed |
| HMGA1 And HAND1 Expression And Their Significance In Laryngeal Cancer Tissues. | J Vis Exp | 2026 | 42330068 | PubTator, text mining | PubMed |
| Glucocorticoid and mitophagy signaling-based molecular subtyping reveals HMGA1 as a prognostic and immunotherapy biomarker in lung adenocarcinoma. | NPJ Precis Oncol | 2026 | 42321301 | PubTator, text mining | PubMed |
| Chromoanagenesis in Myelodysplastic Syndromes Is Associated With Highly Complex Karyotype, TP53 Disruption, and Dismal Prognosis. | Mod Pathol | 2026 | 42320760 | PubTator, text mining | PubMed |
| Expression and Survival Analysis Show High Mobility Group (HMG) Family as Prognostic Biomarkers in Breast Cancer. | Eur J Breast Health | 2026 | 42310973 | PubTator, text mining | PubMed |
| Genome-wide identification and expression profiling of the HMGR gene family in Bupleurum chinense DC. | BMC Plant Biol | 2026 | 42271220 | PubTator, text mining | PubMed |
| EXPRESSION OF CONCERN: Intracellular FGF1 promotes invasion and migration in thyroid carcinoma via HMGA1 independent of FGF receptors. | Endocr Connect | 2026 | 42259385 | PubTator, text mining | PubMed |
Compartmentalized co-cultivation and temporal transcriptomics reveal SexM-mediated crosstalk between pheromone signaling and metabolic reprogramming in the industrial carotenoid producer Blakeslea trispora. | Genomics | 2026 | 42202948 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3159/papers